pcDNA3.1-beta-3 Citations (12)
Originally described in: Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling.Takagi J, Petre BM, Walz T, Springer TA Cell. 2002 Sep 6. 110(5):599-11. PubMed Journal
Articles Citing pcDNA3.1-beta-3
| Articles |
|---|
| FOSL1 controls the assembly of endothelial cells into capillary tubes by direct repression of alphav and beta3 integrin transcription. Evellin S, Galvagni F, Zippo A, Neri F, Orlandini M, Incarnato D, Dettori D, Neubauer S, Kessler H, Wagner EF, Oliviero S. Mol Cell Biol. 2013 Mar;33(6):1198-209. doi: 10.1128/MCB.01054-12. Epub 2013 Jan 14. PubMed |
| Conformational coupling of integrin and Thy-1 regulates Fyn priming and fibroblast mechanotransduction. Fiore VF, Strane PW, Bryksin AV, White ES, Hagood JS, Barker TH. J Cell Biol. 2015 Oct 12;211(1):173-90. doi: 10.1083/jcb.201505007. PubMed |
Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow.
Wang L, Luo JY, Li B, Tian XY, Chen LJ, Huang Y, Liu J, Deng D, Lau CW, Wan S, Ai D, Mak KK, Tong KK, Kwan KM, Wang N, Chiu JJ, Zhu Y, Huang Y.
Nature. 2016 Dec 7. doi: 10.1038/nature20602.
PubMed
Associated Plasmids |
| Transient mechanical strain promotes the maturation of invadopodia and enhances cancer cell invasion in vitro. Gasparski AN, Ozarkar S, Beningo KA. J Cell Sci. 2017 Jun 1;130(11):1965-1978. doi: 10.1242/jcs.199760. Epub 2017 Apr 26. PubMed |
| Oral Administration and Detection of a Near-Infrared Molecular Imaging Agent in an Orthotopic Mouse Model for Breast Cancer Screening. Bhatnagar S, Verma KD, Hu Y, Khera E, Priluck A, Smith DE, Thurber GM. Mol Pharm. 2018 May 7;15(5):1746-1754. doi: 10.1021/acs.molpharmaceut.7b00994. Epub 2018 Apr 26. PubMed |
| Dysregulation of the MiR-449b target TGFBI alters the TGFbeta pathway to induce cisplatin resistance in nasopharyngeal carcinoma. Bissey PA, Law JH, Bruce JP, Shi W, Renoult A, Chua MLK, Yip KW, Liu FF. Oncogenesis. 2018 May 22;7(5):40. doi: 10.1038/s41389-018-0050-x. PubMed |
| Src kinase phosphorylates Notch1 to inhibit MAML binding. LaFoya B, Munroe JA, Pu X, Albig AR. Sci Rep. 2018 Oct 19;8(1):15515. doi: 10.1038/s41598-018-33920-y. PubMed |
| PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin beta3. Soriano AA, de Cristofaro T, Di Palma T, Dotolo S, Gokulnath P, Izzo A, Cali G, Facchiano A, Zannini M. Cancer Cell Int. 2019 Nov 20;19:303. doi: 10.1186/s12935-019-1022-8. eCollection 2019. PubMed |
| Defining the TLT-1 interactome from resting and activated human platelets. Schmoker AM, Perez Pearson LM, Cruz C, Colon Flores LG, Branfeild S, Pagan Torres FD, Fonseca K, Cantres YM, Salgado Ramirez CA, Melendez LM, Ballif BA, Washington AV. J Proteomics. 2020 Mar 20;215:103638. doi: 10.1016/j.jprot.2020.103638. Epub 2020 Jan 8. PubMed |
| Measurement of Integrin Activation and Conformational Changes on the Cell Surface by Soluble Ligand and Antibody Binding Assays. Wang Z, Zhu J. Methods Mol Biol. 2021;2217:3-15. doi: 10.1007/978-1-0716-0962-0_1. PubMed |
| MIIP functions as a novel ligand for ITGB3 to inhibit angiogenesis and tumorigenesis of triple-negative breast cancer. Gao Y, Fang Y, Huang Y, Ma R, Chen X, Wang F, Pei X, Gao Y, Chen X, Liu X, Shan J, Li P. Cell Death Dis. 2022 Sep 21;13(9):810. doi: 10.1038/s41419-022-05255-0. PubMed |
| Integrin-alphavbeta3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance. Echavidre W, Durivault J, Gotorbe C, Blanchard T, Pagnuzzi M, Vial V, Raes F, Broisat A, Villeneuve R, Amblard R, Garnier N, Ortholan C, Faraggi M, Serrano B, Picco V, Montemagno C. Cancer Res Commun. 2023 Dec 7;3(12):2483-2496. doi: 10.1158/2767-9764.CRC-23-0298. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.